Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease breast cancer
Symptom C0151825|bone pain
Sentences 6
PubMedID- 24069136 Large scale clinical trials have demonstrated that bisphosphonates reduce tumour burden and prevent further bone loss in animal models as well as reducing bone pain in patients with breast cancer metastasis by targeting the tumour cells, angiogenesis and the bone microenvironment.
PubMedID- 23334120 Conclusions: this study indicated that (177)lu-edtmp was an effective and safe treatment for palliation of metastatic bone pain in patients with prostate or breast cancer.
PubMedID- 26237068 A small number of trials have shown that radioisotopes can relieve bone pain in patients with breast cancer and lung cancer, while inconsistent results were produced in patients with hormone-refractory prostate cancer .
PubMedID- 26024743 Incidence of bone pain in patients with breast cancer treated with lipegfilgrastim or pegfilgrastim: an integrated analysis from phase ii and iii studies.
PubMedID- 20151162 bone pain reduction in patients with metastatic breast cancer treated with ibandronate-results from a post-marketing surveillance study.
PubMedID- 22903605 Taken together, these results suggest cb(2) agonists as a novel treatment for breast cancer-induced bone pain, in which disease modifications include a reduction in bone loss, suppression of cancer growth, attenuation of severe bone pain, and increased survival without the major side effects of current therapeutic options.

Page: 1